In-vivo characterization of MYCN-driven immunosuppression |
University of California San Francisco / William Weiss, MD/PhD |
Innovation Grants |
2021 |
California |
Single-Cell Profiling of Acute Myeloid Leukemia for High-Resolution Chemo-immunotherapy Target Discovery |
Stanford University School of Medicine / Charles Gawad, MD/PhD |
Single-cell Pediatric Cancer Atlas Grant |
2019 |
California |
Predicting Outcome and Ameliorating Toxicities of the Immunotherapy of Neuroblastoma |
University of California, San Diego / Alice Yu, MD, PhD |
Innovation Grants |
2011 |
California |
MLL Oncogene-Dependent Enhancer Reprogramming Promotes Leukemogenesis |
Stanford University / Feng Pan, PhD |
Young Investigator Grants |
2019 |
California |
The role of OCT4 in self-renewal signaling and drug-resistance of childhood acute lymphoblastic leukemia
|
Children's Hospital Los Angeles / Markus Muschen |
Innovation Grants |
2008 |
California |
Maternal Comorbidities, Pharmaceutical Use and Childhood Cancers: A Record Linkage Study in Taiwan |
University of California, Los Angeles / Julia Heck, PhD |
Epidemiology Grants |
2017 |
California |
Determinants of Testicular Germ Cell Tumor Platinum Sensitivity and Resistance |
University of California, San Diego / Paolo Abada |
Young Investigator Grants |
2012 |
California |
Investigating the Role of Genetic and Epigenetic Variation in Risk of Childhood Acute Lymphoblastic Leukemia in Down Syndrome |
University of California San Francisco / Adam de Smith, Ph.D. |
'A' Award Grants |
2014 |
California |
Defining the Role of a Novel, Developmentally Restricted Hematopoietic Stem Cell in Pediatric Leukemias |
University of California at Santa Cruz / Camilla Forsberg, PhD |
Innovation Grants |
2013 |
California |
Enhancing Effectiveness of Immune Checkpoint Therapy in Neuroblastoma |
Children's Hospital Los Angeles / Shahab Asgharzadeh, MD |
Innovation Grants |
2015 |
California |